Skip to main content

Table 1 Baseline characteristics of study cohort (n = 79)

From: Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer

Variables

n (%)

mediana(IQR)

Age

 

69.0 (65.0 – 73.0)

Place of residence

 Urban

56 (70.9)

 

 Rural

23 (29.1)

 

Initial Clinical presentation

 LUTS

69 (87.3)

 

bNSAID use

51 (64.6)

 

 Anaemia (<10 g/dL)

25 (31.6)

 

PADT received

  

 Orchiectomy

65(82.3)

 

 LH-RH analogues

14 (17.7)

 

PSA kinetics

 Pre-treatment PSA(ng/mL)

 

94.0 (50.0 – 124.0)

 PSA nadir (ng/mL)

 

4.0 (1.0 – 9.0)

 PSA decline

  

   ≥ 90%

60 (75.9)

 

   < 90%

19 (24.1)

 

Biopsy Gleason score

 3 + 3

24 (30.4)

 

 3 + 4

10 (12.7)

 

 4 + 3

20 (25.3)

 

  ≥ 8

25 (31.7)

 
  1. aInterquartile range, bNon-steroidal anti-inflammatory drugs